“The FDA Director General Eric Domingo says they are considering Ivemectin and Leronlimab for DEU (EUA equivilant).”

Very interesting video. Let’s see what happens in the coming weeks I’m the PI I’m regards to an EUA. Any revenue that can help fund the India/Brazil trials is needed as Fife loans only dilute shareholders and like Fife’s pockets (the mans a genius).